Fig 1.
CONSORT diagram. AC, doxorubicin plus cyclophosphamide; AC→P, doxorubicin plus cyclophosphamide followed by paclitaxel; ER, estrogen receptor; GHI, Genomic Health, Inc.; IBC, invasive breast cancer; NSABP, National Surgical Adjuvant Breast and Bowel Project; qPCR, quantitative polymerase chain reaction; RT-PCR, reverse transcriptase polymerase chain reaction; RTX, radiotherapy; TAM, tamoxifen.